Days At A Glance Speakers Session Type Search
Type

    12:00 - 20:00 
    Registration
    17:30 - 19:30 
    Opening Ceremony: Geoffrey Harris Prize Lecture
    HALL 1
    Chair: E. Nieschlag (Germany), President ESE
    GH1
    Opening Ceremony: Geoffrey Harris Prize Lecture
    From Geoffrey Harris' hypothalamic principle to a unified theory of stress and stress system disorders
    17:30 - 19:30 
    Opening Ceremony: European Journal of Endocrinology Prize Lecture
    HALL 1
    Chair: C. Strasburger (Germany), Editor EJE
    EJE1
    Opening Ceremony: European Journal of Endocrinology Prize Lecture
    Sex Steroids in the Regulation of Bone Metabolism in Men
    19:30 - 22:00 
    Welcome Reception
    EXHIBITION

    08:30 - 10:00 
    Symposium 1 - Clinical: The trick is the combination
    HALL 1
    Chairs: A. van der Lely (Netherlands) & V. Pirags (Lithuania)
    S1.1
    Symposium 1 - Clinical: The trick is the combination
    Treatment of hyperthyroidism: block and replace versus titration
    S1.2
    Symposium 1 - Clinical: The trick is the combination
    The combination of GH/IGF-I makes the difference!
    S1.3
    Symposium 1 - Clinical: The trick is the combination
    Medical Treatment of Acromegaly: Dual Blockade with a Somatostatin Analog and Pegvisomant
    S1.4
    Symposium 1 - Clinical: The trick is the combination
    The combined Androgen and Estrogen replacement therapy in women
    08:30 - 10:00 
    Symposium 2 - Basic: The TGF-beta Superfamily
    HALL 7
    Chairs: C.V. Alvarez (Spain) & D. Salvatore (Italy)
    S2.1
    Symposium 2 - Basic: The TGF-beta Superfamily
    BMP to the Bone
    S2.2
    Symposium 2 - Basic: The TGF-beta Superfamily
    Integration of Skeletal Regulatory Signals in Nuclear Microenvironments
    S2.3
    Symposium 2 - Basic: The TGF-beta Superfamily
    TGF-beta family ligands in glucose and fat homeostasis in adults
    S2.4
    Symposium 2 - Basic: The TGF-beta Superfamily
    The Dependence Receptor notion: When apoptosis regulates tumor progression and metastasis
    08:30 - 10:00 
    Symposium 3 - Translational: Gene / Environment interactions in autoimmune endocrine disease
    HALL 3
    Chairs: M. Knip (Finland) & G. Krassas (Greece)
    S3.1
    Symposium 3 - Translational: Gene / Environment interactions in autoimmune endocrine disease
    Why is the incidence of autoimmune diseases increasing in the modern world?
    S3.2
    Symposium 3 - Translational: Gene / Environment interactions in autoimmune endocrine disease
    Genome-wide association studies and hormone-dependent cancers
    S3.3
    Symposium 3 - Translational: Gene / Environment interactions in autoimmune endocrine disease
    Gene Environment Interactions in Type 1 Diabetes
    S3.4
    Symposium 3 - Translational: Gene / Environment interactions in autoimmune endocrine disease
    Gene-environment interactions in thyroid autoimmunity.
    10:05 - 10:50 
    Plenary Lecture 1
    Supported by Bayer-Schering Pharma
    HALL 1
    Chairs: S. Lamberts (Netherlands) & F. Casanueva (Spain)
    PL1
    Plenary Lecture 1
    Estrogens and cardiovascular disease
    10:50 - 11:15 
    Coffee Break & Exhibition
    11:15 - 12:45 
    Symposium 4 - Clinical: Is there a crisis of male reproduction?
    HALL 1
    Chairs: A. Milewicz (Poland) & M. Simoni (Italy)
    S4.1
    Symposium 4 - Clinical: Is there a crisis of male reproduction?
    Deterioration of male reproductive function in Europe. Geographical differences
    S4.2
    Symposium 4 - Clinical: Is there a crisis of male reproduction?
    Life style factors and chemical exposures impair male reproductive development and function in humans
    S4.3
    Symposium 4 - Clinical: Is there a crisis of male reproduction?
    Metabolic syndrome in Klinefelter syndrome (47,XXY)
    S4.4
    Symposium 4 - Clinical: Is there a crisis of male reproduction?
    Metabolic Aspects of Testosterone Replacement
    11:15 - 12:45 
    Symposium 5 - Basic: Protein modifications / Proteomics
    HALL 7
    Chairs: S.B. Bravo (Spain) & A.Vidal (Spain)
    S5.1
    Symposium 5 - Basic: Protein modifications / Proteomics
    Comparative proteomics as a tool in biology: The protein microscope
    S5.2
    Symposium 5 - Basic: Protein modifications / Proteomics
    Applying proteomics to thyroid tumour diagnosis
    S5.3
    Symposium 5 - Basic: Protein modifications / Proteomics
    Targeting ubiquitin networks
    S5.4
    Symposium 5 - Basic: Protein modifications / Proteomics
    Progesterone Receptor Responses Modified by SUMO in the Endometrium
    11:15 - 12:45 
    Symposium 6 - Translational: Insights in pancreatic development and new clinical aspects
    HALL 3
    Chairs: K. Raile (Germany) & G. Bolli (Italy)
    S6.1
    Symposium 6 - Translational: Insights in pancreatic development and new clinical aspects
    Embryonic Pancreatic Development
    S6.2
    Symposium 6 - Translational: Insights in pancreatic development and new clinical aspects
    The zinc-finger factor Insm1 (IA-1) is essential for the development of endocrine cells of the pancreas, intestine and adrenal gland.
    S6.3
    Symposium 6 - Translational: Insights in pancreatic development and new clinical aspects
    Hyperinsulinism in humans
    S6.4
    Symposium 6 - Translational: Insights in pancreatic development and new clinical aspects
    Carboxylester lipase (CEL) VNTR links exocrine dysfunction to endocrine dysfunction
    11:15 - 12:45 
    Oral Communication 1: Neuroendocrinology & Pituitary
    HALL 4/5
    Chairs: S. Tsagarakis (Greece) & A. Giustina (Italy)
    OC1.1
    Oral Communication 1: Neuroendocrinology & Pituitary
    Structured assessment of neuroendocrine dysfunction following traumatic brain injury and aneurysmal subarachnoid hemorrhage in 921 patients – the German Interdisciplinary Database
    OC1.2
    Oral Communication 1: Neuroendocrinology & Pituitary
    The adequacy of thyroxine replacement in hypopituitary patients
    OC1.3
    Oral Communication 1: Neuroendocrinology & Pituitary
    Limited effects of Growth Hormone Replacement in Adultswith Growth Hormone Deficiency after Treatment for Acromegaly
    OC1.4
    Oral Communication 1: Neuroendocrinology & Pituitary
    Pasireotide (SOM230) effectively reduces pituitary tumor volume in patients with active acromegaly: preliminary 6-month results from a Phase II extension study
    OC1.5
    Oral Communication 1: Neuroendocrinology & Pituitary
    CARDIAC PERFORMANCE AFTER LONG-TERM TREATMENT WITH PEGVISOMANT IN PATIENTS WITH ACROMEGALIC : A RADIONUCLIDE ANGIOGRAPHY STUDY.
    OC1.6
    Oral Communication 1: Neuroendocrinology & Pituitary
    The metabolic effects of ghrelin and glucocorticoids are mediated by AMP-activated protein kinase (AMPK) and endogenous cannabinoids
    OC1.7
    Oral Communication 1: Neuroendocrinology & Pituitary
    INTERMITTENT HIGH GLUCOSE CONCENTRATIONS REDUCE NEURONAL PRECURSOR PROLIFERATION BY ALTERING THE IGF SYSTEM: THE INVOLVEMENT OF THE NEUROPROTECTIVE FACTOR SELADIN-1.
    OC1.8
    Oral Communication 1: Neuroendocrinology & Pituitary
    Differential sensitivity of men and women to anorexigenic and memory improving effects of intranasal insulin
    OC1.9
    Oral Communication 1: Neuroendocrinology & Pituitary
    Oxytocin alleviates the neuroendocrine and cytokine response to bacterial endotoxin in healthy men
    13:00 - 14:30 
    Satellite Symposium: Lilly - New treatment approaches for type 2 diabetes mellitus that target pathophysiology
    HALL 3
    13:00 - 14:30 
    Satellite Symposium: Ipsen - Pathogenesis & management of aggressive pituitary tumours
    HALL 1
    13:00 - 15:00 
    Lunch
    13:00 - 15:00 
    Poster session
    14:30 - 15:30 
    Meet the Expert 1: The impact of abdominal obesity
    HALL 1
    ME1
    Meet the Expert 1: The impact of abdominal obesity
    The impact of abdominal obesity
    14:30 - 15:30 
    Meet the Expert 2: The necessity of Insulin analogues
    HALL 7
    ME2
    Meet the Expert 2: The necessity of Insulin analogues
    Rational for using insulin analogues in the treatment of diabetes mellitus
    14:30 - 15:30 
    Meet the Expert 3: Contraception in the new millennium
    HALL 3
    ME3
    Meet the Expert 3: Contraception in the new millennium
    Contraception in the New Millennium
    14:30 - 15:30 
    Meet the Expert 4: A living method: In vivo microscopy
    HALL 4/5
    ME4
    Meet the Expert 4: A living method: In vivo microscopy
    Two-photon microscopy of cancer invasion and metastasis
    15:30 - 17:00 
    Symposium 7 - Translational: The functions of peripheral GHrelin
    HALL 1
    Chairs: C. Dieguez (Spain) & M. Korbonits (United Kingdom)
    S7.1
    Symposium 7 - Translational: The functions of peripheral GHrelin
    Ghrelin and the Gonads
    S7.2
    Symposium 7 - Translational: The functions of peripheral GHrelin
    Ghrelin and the endocrine pancreas
    S7.3
    Symposium 7 - Translational: The functions of peripheral GHrelin
    Ghrelin and Bone
    S7.4
    Symposium 7 - Translational: The functions of peripheral GHrelin
    Peptidyl growth hormone secretagogues in cardioprotection
    15:30 - 17:00 
    Symposium 8 - Basic: Nuclear Receptors
    HALL 7
    Chairs: A. Aranda (Spain) & G. Vollmer (Germany)
    S8.1
    Symposium 8 - Basic: Nuclear Receptors
    LXR
    S8.2
    Symposium 8 - Basic: Nuclear Receptors
    Kinase signaling and retinoic acid nuclear receptors
    S8.3
    Symposium 8 - Basic: Nuclear Receptors
    Phosphorylation of histone H3 at threonine 11 establishes a novel chromatin mark for transcriptional regulation
    S8.4
    Symposium 8 - Basic: Nuclear Receptors
    Estrogen-related receptors as regulators of energy homeostasis and adaptive metabolism
    15:30 - 17:00 
    Symposium 9 - Clinical: New aspects of adrenal disease
    HALL 3
    Chairs: B. Allolio (Germany) & J. Bertherat (France)
    S9.1
    Symposium 9 - Clinical: New aspects of adrenal disease
    The role of toll-like receptors
    S9.2
    Symposium 9 - Clinical: New aspects of adrenal disease
    The expanding spectrum of DAX1 and SF1 mutations
    S9.3
    Symposium 9 - Clinical: New aspects of adrenal disease
    REPLACEMENT AND QoL IN PATIENTS WITH ADRENAL INSUFFICIENCY
    S9.4
    Symposium 9 - Clinical: New aspects of adrenal disease
    Genetics of chromaffin tumours
    15:30 - 17:00 
    Oral Communication 2: Thyroid
    HALL 4/5
    Chairs: R. Elisei (Italy) & B. Jarzab (Poland)
    OC2.1
    Oral Communication 2: Thyroid
    Analysis of early gene expression in mouse thyroid development
    OC2.2
    Oral Communication 2: Thyroid
    Identification of 25 novel NKX2-1 gene mutations in 100 patients with broad spectrum of brain and thyroid dysfunctions
    OC2.3
    Oral Communication 2: Thyroid
    Global Proteomic analysis in human thyroid proliferative/neoplastic primary culture lines
    OC2.4
    Oral Communication 2: Thyroid
    Identification and enrichment of thyroid stem cells in anaplastic cell lines.
    OC2.5
    Oral Communication 2: Thyroid
    Fetal cell microchimerism in papillary thyroid cancer: A possible role in tumor damage and tissue repair
    OC2.6
    Oral Communication 2: Thyroid
    Ga-68-Dotatoc PET detects Somatostatin receptors in normal thyroids and various thyroid pathologies
    OC2.7
    Oral Communication 2: Thyroid
    Impact of Resistance to Thyroid Hormone on the Cardiovascular System in Adult Humans
    OC2.8
    Oral Communication 2: Thyroid
    Graves’ ophthalmopathy in patients treated with radioiodine I-131
    OC2.9
    Oral Communication 2: Thyroid
    Subclinical hypothyroidism in older patients: an analysis of natural course and risk factors for the thyroid failure
    17:15 - 18:00 
    Plenary Lecture 2
    HALL 1
    Chairs: I. Gerendai (Hungary) & J. Wass (United Kingdom)
    PL2
    Plenary Lecture 2
    Why did Moses live to be 120?
    18:00 - 18:15 
    Coffee
    18:15 - 19:45 
    Satellite Symposium: Novartis Oncology - Optimal management of acromegaly - today, tomorrow and throughout a patient's life
    HALL 3
    18:15 - 19:45 
    Satellite Symposium: Pfizer - KIMS Highlights: Does GH replacement have an impact on mortality rate in adult hypopituitary patients?
    HALL 1

    08:30 - 10:00 
    Symposium 10 - Pro & Con: Is there a rationale for ISS treatment with GH
    HALL 1
    Chair: P. Clayton (UK)
    Symposium 10 - Pro & Con: Is there a rationale for ISS treatment with GH
    CON
    Symposium 10 - Pro & Con: Is there a rationale for ISS treatment with GH
    PRO
    08:30 - 10:00 
    Symposium 11 - Basic: Epigenetics in endocrinology
    HALL 7
    Chairs: H. Krude (Germany) & L. Hofland (Netherlands)
    S11.1
    Symposium 11 - Basic: Epigenetics in endocrinology
    Epimutations in the human genome
    S11.2
    Symposium 11 - Basic: Epigenetics in endocrinology
    Mechanisms of selective gene expression in development
    S11.3
    Symposium 11 - Basic: Epigenetics in endocrinology
    Epigenetics in mammalian development
    S11.4
    Symposium 11 - Basic: Epigenetics in endocrinology
    Imprinting in Human Disease – Lessons from the study of Transient Neonatal Diabetes
    08:30 - 10:00 
    Symposium 12 - Translational: Addicted to Food?
    HALL 3
    Chairs: S. Farooqi (UK) & V. Popovic (Serbia)
    S12.1
    Symposium 12 - Translational: Addicted to Food?
    The Selfish Brain: Competition for Energy Resources
    S12.2
    Symposium 12 - Translational: Addicted to Food?
    Peptide YY: Cure for obesity?
    S12.3
    Symposium 12 - Translational: Addicted to Food?
    Hypothalamic regulation of energy balance
    S12.4
    Symposium 12 - Translational: Addicted to Food?
    Metabolic and reward cues affect the central clock in the brain
    08:30 - 10:00 
    DGE Hormone Toxicology: Is there a threat of endocrine disruptors?
    HALL 4/5
    Chairs: A. Pfeiffer (Berlin) & G. Vollmer (Dresden)
    DGE Hormone Toxicology: Is there a threat of endocrine disruptors?
    Endocrine disruptors and the thyroid
    DGE Hormone Toxicology: Is there a threat of endocrine disruptors?
    Endocrine disruptors and reproductive hormones
    DGE Hormone Toxicology: Is there a threat of endocrine disruptors?
    Plant derived compunds with endocrine actions: Hops and Xanthohumols
    DGE Hormone Toxicology: Is there a threat of endocrine disruptors?
    Danger of combination? Interactions of low ose hormone therapy with phytoestrogens
    10:05 - 10:50 
    Plenary Lecture 3
    HALL 1
    Chairs: T. Gudermann (Germany) & R. Gaillard (Switzerland)
    PL3
    Plenary Lecture 3
    A cofactor network that controls PGC-1alpha activity and energy homeostasis
    10:50 - 11:15 
    Coffee Break & Exhibition
    11:15 - 12:45 
    Symposium 13 - Pro & Con: HRT or more Androgen therapy of the aging male
    Supported by Bayer Schering Pharma
    HALL 1
    Chair: P. Bouchard (France)
    Symposium 13 - Pro & Con: HRT or more Androgen therapy of the aging male
    CON
    Symposium 13 - Pro & Con: HRT or more Androgen therapy of the aging male
    PRO
    11:15 - 12:45 
    Symposium 14: Basic Highlights
    HALL 7
    Chairs: J. Castano (Spain) & J. C. Moreno (Netherlands)
    S14.1
    Symposium 14: Basic Highlights
    Direct vizualization of cyclic AMP levels in three dimensional cultures of thyroid follicles
    Germany
    S14.2
    Symposium 14: Basic Highlights
    Dopamine receptor 2 activation reduces cells viability in non functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion
    S14.3
    Symposium 14: Basic Highlights
    Variants of the phosphodiesterase 11A (PDE11A4) gene and genetic predisposition to adrenocortical tumors (ACT)
    S14.4
    Symposium 14: Basic Highlights
    Targeted disruption of Slc2a8 (GLUT8) reduces ATP levels and mitochondrial potential of spermatozoa
    S14.5
    Symposium 14: Basic Highlights
    KLF11 differentially regulates PDX1-induced activation of the human insulin promoter in rodent beta-cells and human non-beta-cells
    S14.6
    Symposium 14: Basic Highlights
    Specific neuronal deletion of cannabinoid type 1 receptor (CB1) mice exhibits reduced fat mass and diet-induced obesity resistance
    11:15 - 12:45 
    Symposium 15 - Clinical: GH treatment of syndromic short stature-facts and myths
    HALL 3
    Chairs: M. Ranke (Germany) & D. Micic (Serbia)
    S15.1
    Symposium 15 - Clinical: GH treatment of syndromic short stature-facts and myths
    SHOX Deficiency: Does GH Treatment Do any Good?
    S15.2
    Symposium 15 - Clinical: GH treatment of syndromic short stature-facts and myths
    GH therapy in Noonan Syndrome – facts and myths
    S15.3
    Symposium 15 - Clinical: GH treatment of syndromic short stature-facts and myths
    GH therapy in children with Prader Willi Syndrome (PWS)
    S15.4
    Symposium 15 - Clinical: GH treatment of syndromic short stature-facts and myths
    Consensus on GH Treatment in SGA
    11:15 - 12:45 
    Oral Communication 3: Diabetes and Obesity
    HALL 4/5
    Chairs: M. Coculescu (Romania) & U. Pagotto (Italy)
    OC3.1
    Oral Communication 3: Diabetes and Obesity
    Interaction of hypothalamic G-protein-coupled receptors (GPCRs) involved in weight regulation
    OC3.2
    Oral Communication 3: Diabetes and Obesity
    Adiponectin inhibits AMP kinase activity and increases insulin secretion in MIN6 cells
    OC3.3
    Oral Communication 3: Diabetes and Obesity
    Regulation of lipolysis by corticotropin releasing hormone in brown adipocytes
    OC3.4
    Oral Communication 3: Diabetes and Obesity
    Fatty acid-induced induction of TLR-4/NFkB-pathway in adipocytes links nutritional signaling with innate immunity
    OC3.5
    Oral Communication 3: Diabetes and Obesity
    Hormonal regulation of 11-β-HSD1 expression and activity in differentiated 3T3- L1 adipocytes
    OC3.6
    Oral Communication 3: Diabetes and Obesity
    Transcriptional control of hepatic and systemic lipid metabolism by the nuclear receptor co-factor RIP140
    OC3.7
    Oral Communication 3: Diabetes and Obesity
    Impact of metformin on gene expression, glucose uptake and lipolysis in adipocytes
    OC3.8
    Oral Communication 3: Diabetes and Obesity
    Retrovirally transduced, antigen-specific T cells for therapy of type 1 diabetes
    OC3.9
    Oral Communication 3: Diabetes and Obesity
    Effect of baseline sample characteristics, comparator drug, co-interventions and rosigitazone doses on the risk of myocardial infarction. Multivariable lineal regression analysis
    13:00 - 14:30 
    Satellite Symposium: Pfizer - The role of pegvisomant in the current treatment of acromegaly
    HALL 1
    13:00 - 14:30 
    Lunch
    13:00 - 15:30 
    STAND BY ME!! SESSION
    All poster authors will discuss posters during lunch. Members of the Executive & Program Committees will be active participants.
    EXHIBITION & UPPER FLOOR
    14:30 - 15:30 
    Meet the Expert 5: How valid is a biochemical diagnosis of chromaffin tumors?
    HALL 1
    ME5
    Meet the Expert 5: How valid is a biochemical diagnosis of chromaffin tumors?
    How valid is a biochemical diagnosis of chromaffin tumors?
    14:30 - 15:30 
    Meet the Expert 6: Beyond the bone – sporadic and hereditary hyperparathyroidism.
    HALL 7
    ME6
    Meet the Expert 6: Beyond the bone – sporadic and hereditary hyperparathyroidism.
    Beyond the bone – sporadic and hereditary hyperparathyroidism.
    14:30 - 15:30 
    Meet the Expert 7: The sequelae of brain injury – is the pituitary involved?
    HALL 3
    ME7
    Meet the Expert 7: The sequelae of brain injury – is the pituitary involved?
    The sequelae of brain injury – is the pituitary involved?
    14:30 - 15:30 
    Meet the Expert 8: MicroRNA
    HALL 4/5
    ME8
    Meet the Expert 8: MicroRNA
    microRNA
    15:30 - 17:00 
    Symposium 16 - Clinical: New insights in PCOS
    HALL 1
    Chairs: A. Milewicz (Poland) & S. Christin-Maitre (France)
    S16.1
    Symposium 16 - Clinical: New insights in PCOS
    Definition of PCOS
    S16.2
    Symposium 16 - Clinical: New insights in PCOS
    New insights in Polycystic Ovary Syndrome
    S16.3
    Symposium 16 - Clinical: New insights in PCOS
    Vascular markers in PCOS
    S16.4
    Symposium 16 - Clinical: New insights in PCOS
    Treatment of PCOS
    15:30 - 17:00 
    Symposium 17 - Basic: Thyroid Cell Biology
    HALL 7
    Chairs: J. Köhrle (Germany) & T.Visser (Netherlands)
    S17.1
    Symposium 17 - Basic: Thyroid Cell Biology
    Basic mechanisms of thyroid development
    S17.2
    Symposium 17 - Basic: Thyroid Cell Biology
    Growth Factors Involved In Thyroid Cells Differentiation
    S17.3
    Symposium 17 - Basic: Thyroid Cell Biology
    Molecular mechanisms of thyroid carcinogenesis: role of the CBX7 gene.Loss of the CBX7 gene.ll
    S17.4
    Symposium 17 - Basic: Thyroid Cell Biology
    Novel insights on the Na+/I- symporter (NIS): it mediates electroneutral active transport of the environmental pollutant perchlorate.
    15:30 - 17:00 
    Oral Communication 4: Bone & Adrenal
    HALL 4/5
    Chairs: D. Schnabel (Germany) & A. Leal-Cerro (Spain)
    OC4.1
    Oral Communication 4: Bone & Adrenal
    Inactivation of the Carney Complex (CNC) gene 1 (PKA regulatory subunit 1A, PRKAR1A) by interference RNA alters multiple signaling pathways and decreases apoptosis.
    OC4.2
    Oral Communication 4: Bone & Adrenal
    Reduced fertility rates and high prevalence of testicular adrenal rest tumors (TART) in male patients with congenital adrenal hyperplasia
    OC4.3
    Oral Communication 4: Bone & Adrenal
    BMP dependent modulation of adrenocortical growth and function
    OC4.4
    Oral Communication 4: Bone & Adrenal
    Comparison of different test systems for the screening of inhibitors of CYP11B enzymes
    OC4.5
    Oral Communication 4: Bone & Adrenal
    Comparison of 1-mg versus 8-mg dexamethasone suppression tests (DST) in patients with clinically inapparent adrenal adenoma.
    OC4.6
    Oral Communication 4: Bone & Adrenal
    Isolation and characterization of cells coexpressing endothelial progenitors and parathyroid specific genes from human adult normal and tumoral parathyroids
    OC4.7
    Oral Communication 4: Bone & Adrenal
    Molecular analysis of the calcium sensing receptor (CASR) gene in 40 patients clinically suspected to have familial hypocalciuric hypercalcemia (FHH)
    OC4.8
    Oral Communication 4: Bone & Adrenal
    Incidental parathyroidectomy during thyroid surgery: outcome, follow-up and management of 231 patients treated between 1989 and 2007
    OC4.9
    Oral Communication 4: Bone & Adrenal
    Teriparatide (TPTD) Treatment Followed by Either Zoledronic Acid (ZOL) 5mg Once Yearly or Strontium Ranelate (SR) 2g Daily: Preliminary Results from the ZOSTER-Study
    15:30 - 17:00 
    DGE Symposium Young Reasearchers (DGE): Embryonic Development of Endocrine Organs
    Sponsored by Merck Serono
    HALL 3
    Chairs: B. Allolio (Würzburg) & O. Hiort (Lübeck)
    DGE Symposium Young Reasearchers (DGE): Embryonic Development of Endocrine Organs
    Trekking the midline-development of the hypothalamus and the pituitary
    DGE Symposium Young Reasearchers (DGE): Embryonic Development of Endocrine Organs
    Sexual differentiation - What makes the difference?
    DGE Symposium Young Reasearchers (DGE): Embryonic Development of Endocrine Organs
    A long way from its roots - the pancreatic beta cell
    DGE Symposium Young Reasearchers (DGE): Embryonic Development of Endocrine Organs
    Walking the line - the thyroid gland development
    17:15 - 18:00 
    Plenary Lecture 4
    Berthold Lecture of the German Endocrine Society (DGE) Awards
    HALL 1
    Chairs: A. Grueters (Germany) & T. Gudermann (Germany)
    PL4
    Plenary Lecture 4
    Genetics of Obesity
    18:00 - 19:30 
    General Assembly German Endocrine Society (DGE)
    HALL 1
    20:00 - 23:00 
    ECE Congress Party at Wasserwerk
    Wasserwerk

    08:30 - 10:00 
    Symposium 18 - Clinical: Doping - an issue for clinical endocrinologists
    HALL 1
    Chairs: J. Christiansen (Denmark) & F. Kelestimur (Turkey)
    S18.1
    Symposium 18 - Clinical: Doping - an issue for clinical endocrinologists
    Indirect evidence suggesting hormone abuse -- can it be proof of doping in sports?
    S18.2
    Symposium 18 - Clinical: Doping - an issue for clinical endocrinologists
    Doping with Androgens
    S18.3
    Symposium 18 - Clinical: Doping - an issue for clinical endocrinologists
    Distinction between endogenous and exogenous GH
    S18.4
    Symposium 18 - Clinical: Doping - an issue for clinical endocrinologists
    Distinction between endogenous and exogenous erythropoietin (EPO)
    08:30 - 10:00 
    Symposium 19 - Translational: Hormone receptors and adipose tissue
    HALL 7
    Chairs: H. Lehnert (Germany) & H. Bieberman (Germany)
    S19.1
    Symposium 19 - Translational: Hormone receptors and adipose tissue
    The family of corticotropin-releasing hormone (CRH) peptides; important regulators of adipocyte function
    S19.2
    Symposium 19 - Translational: Hormone receptors and adipose tissue
    Corticosteroid receptors and adipocytes
    S19.3
    Symposium 19 - Translational: Hormone receptors and adipose tissue
    Multi-layered receptor interactions in ghrelin-induced fat deposition
    S19.4
    Symposium 19 - Translational: Hormone receptors and adipose tissue
    Adiponectin and its receptors in insulin resistance, diabetes, and metabolic syndrome, and obesity.
    08:30 - 10:00 
    Symposium 20: Translational Highlights
    HALL 3
    Chairs: J. Lado (Spain) & L. Persani (Italy)
    S20.1
    Symposium 20: Translational Highlights
    sst2 gene transfer restores the somatostatin agonist sensitivity of human resistant pituitary adenomas, in vitro
    S20.2
    Symposium 20: Translational Highlights
    SF-1 knockout mice as a model for hormone independent brain sexual differentiation
    S20.3
    Symposium 20: Translational Highlights
    Monoallelic mutations in DUOXA2 are associated with mild permanent hypothyroidism and goiter.
    S20.4
    Symposium 20: Translational Highlights
    Recent advances in stereological methods for studying microvessels in endocrine organs
    S20.5
    Symposium 20: Translational Highlights
    V206M polymorphism of the SLC26A6 gene encoding a Cl--oxalate transporter in patients with primary hyperparathyroidism and kidney stones.
    S20.6
    Symposium 20: Translational Highlights
    A functional AMH polymorphism is associated with follicle number and androgen levels in Polycystic Ovary Syndrome patients
    10:05 - 10:50 
    Plenary Lecture 5
    HALL 1
    Chairs: P. Trainer (United Kingdom) & K. Raile (Germany)
    PL5
    Plenary Lecture 5
    Too little and too much insulin: lessons from Newborns
    10:50 - 11:15 
    Coffee Break and Exhibition
    11:15 - 12:45 
    Symposium 21 - Pro & Con: Is there a benefit of treatment of subclinical hypothyroidism?
    HALL 1
    Chair: P. Beck-Peccoz (Italy)
    Symposium 21 - Pro & Con: Is there a benefit of treatment of subclinical hypothyroidism?
    CON
    Symposium 21 - Pro & Con: Is there a benefit of treatment of subclinical hypothyroidism?
    PRO
    11:15 - 12:25 
    Symposium 22 - Clinical: The metabolic effects of exercise
    HALL 7
    Chairs: L. Sidossis (Greece) & H. Randeva (United Kingdom)
    S22.1
    Symposium 22 - Clinical: The metabolic effects of exercise
    Mechanisms for the delayed effects of exercise on lipid and lipoprotein metabolism
    S22.2
    Symposium 22 - Clinical: The metabolic effects of exercise
    Inflammation and physical activity
    S22.3
    Symposium 22 - Clinical: The metabolic effects of exercise
    Why does physical exercise improve insulin sensitivity, the role of adipose tissue ?
    S22.4
    Symposium 22 - Clinical: The metabolic effects of exercise
    Exercise and Bone
    11:16 - 12:45 
    Symposium 23 - Translational: Towards a better understanding of hypothalamic - pituitary disorders
    HALL 3
    Chairs: A. Spada (Italy) & R. Pfaffle (Germany)
    S23.1
    Symposium 23 - Translational: Towards a better understanding of hypothalamic - pituitary disorders
    Pituitary Development and Congenital Hypopituitarism (CH)
    S23.2
    Symposium 23 - Translational: Towards a better understanding of hypothalamic - pituitary disorders
    Atypical G-protein coupled receptor expression in pituitary tumors
    S23.3
    Symposium 23 - Translational: Towards a better understanding of hypothalamic - pituitary disorders
    Growth factors in pituitary tumour development
    S23.4
    Symposium 23 - Translational: Towards a better understanding of hypothalamic - pituitary disorders
    Cell cycle control and proliferative diseases of the pituitary
    11:17 - 12:45 
    Oral Communication 5: Reproduction
    HALL 4/5
    Chairs: A. Juul (Denmark) & S. Christin-Maitre (France)
    OC5.1
    Oral Communication 5: Reproduction
    Female Fertility Defects and Puberty Delay in Mice Lacking Activin Receptor-Like Kinase 7
    OC5.2
    Oral Communication 5: Reproduction
    The T222P mutation of the LGR8 gene is not causative for cryptorchidism
    OC5.3
    Oral Communication 5: Reproduction
    Prokineticin-2 and prokineticin receptor-2 gene analysis in men with Kallmann Syndrome or normosmic hypogonadotropic hypogonadism
    OC5.4
    Oral Communication 5: Reproduction
    Molecular and functional characterization of BMP15 variants associated with secondary amenorrhea and Premature Ovarian Failure (POF).
    OC5.5
    Oral Communication 5: Reproduction
    Prevalence of Low Testosterone Levels in Primary Care in Germany: Cross-sectional Results from the DETECT Study
    OC5.6
    Oral Communication 5: Reproduction
    Effects of pregnancy on GH/IGF-1 concentrations in acromegalic women.
    OC5.7
    Oral Communication 5: Reproduction
    HEPATIC STEATOSIS IS NOT A FEATURE OF YOUNG LEAN WOMEN WITH POLYCYSTIC OVARIAN SYNDROME
    OC5.8
    Oral Communication 5: Reproduction
    The effect of estrogens plus cyproterone acetate or orchiectomy on serum insulin like factor 3 (INSL3) levels in transsexual men
    OC5.9
    Oral Communication 5: Reproduction
    Cognitive disabilities in the Novel Object Task of male mice carrying a supernumerary X chromosome (41, XX*Y)
    13:00 - 14:30 
    Satellite Symposium: DuoCort AB - Optimized care for adrenal sufficiency
    ROOM 7
    13:00 - 14:£0 
    Satellite Symposium: Solvay Pharmaceuticals GmbH - Testosterone deficiency syndrome and cerdiovascular co-morbidities
    HALL 1
    13:00 - 14:30 
    Satellite Symposium: Worldwide Merck
    HALL 3
    13:00 - 14:30 
    Lunch
    13:00 - 15:00 
    Poster session
    14:30 - 15:30 
    Meet the Expert 9: An underestimated hormone: Prolactin
    HALL 7
    ME9
    Meet the Expert 9: An underestimated hormone: Prolactin
    Prolactin: An underestimated hormone
    14:30 - 15:30 
    Meet the Expert 10: How to prevent osteoporosis?
    HALL 1
    ME10
    Meet the Expert 10: How to prevent osteoporosis?
    How to prevent osteoporosis?
    14:30 - 15:30 
    Meet the Expert 11: More than a change of nomenclature disorders of sexual differentiation (DSD)
    HALL 3
    ME11
    Meet the Expert 11: More than a change of nomenclature disorders of sexual differentiation (DSD)
    More than a change of nomenclature: Disorders of Sex Development (DSD)
    14:30 - 15:30 
    Meet the Expert 12: Metabolomics and metabolics
    HALL 4/5
    ME12
    Meet the Expert 12: Metabolomics and metabolics
    Metabolomics and metabonomics
    15:30 - 17:00 
    Symposium 24 - Clinical: State of the art in therapy of pituitary disease
    HALL 1
    Chairs: X. Bertagna (France) & A. Grossman (UK)
    S24.1
    Symposium 24 - Clinical: State of the art in therapy of pituitary disease
    Nonfunctioning pituitary macroadenomas: treatment and follow-up
    S24.2
    Symposium 24 - Clinical: State of the art in therapy of pituitary disease
    Medical therapy of Cushing's Disease
    S24.3
    Symposium 24 - Clinical: State of the art in therapy of pituitary disease
    The Sequealae of Cushing’s Disease
    Sheffield, UK
    S24.4
    Symposium 24 - Clinical: State of the art in therapy of pituitary disease
    Development of a disease-related QoL-questionnaire for Cushing’s disease
    15:30 - 17:00 
    Symposium 25 - Basic: Stem cell and regeneration
    HALL 7
    Chairs: G. Schütz (Germany) & S. Bornstein (Germany)
    S25.1
    Symposium 25 - Basic: Stem cell and regeneration
    Generation and patterning of patient-specific pluripotent stem cells
    S25.2
    Symposium 25 - Basic: Stem cell and regeneration
    Stem cells in the gonads: Novel options for fertility preservation?
    S25.3
    Symposium 25 - Basic: Stem cell and regeneration
    The cell biology of neural stem and progenitor cells
    S25.4
    Symposium 25 - Basic: Stem cell and regeneration
    Beta cell progenitor niche(s) and derivation of such cells from human ES cells
    15:30 - 17:00 
    Symposium 26 - Clinical: New therapeutic options in diabetes
    HALL 3
    Chairs: J. Marek (Czech Republic) & U. Pagotto (Italy)
    S26.1
    Symposium 26 - Clinical: New therapeutic options in diabetes
    Islet transplantation
    S26.2
    Symposium 26 - Clinical: New therapeutic options in diabetes
    Regeneration of pancreatic beta cells
    S26.3
    Symposium 26 - Clinical: New therapeutic options in diabetes
    Emerging therapeutic approaches to preserve beta cell function in Type 1 DM
    S26.4
    Symposium 26 - Clinical: New therapeutic options in diabetes
    The one and only? Gene driving Type 2 DM
    15:30 - 17:00 
    Oral Communication 6: Metabolism & Cardiovascular
    HALL 4/5
    Chairs: F. Broglio (Italy) & M. Stummvoll (Germany)
    OC6.1
    Oral Communication 6: Metabolism & Cardiovascular
    The signaling profile of recombinant human orexin-2 receptor (OX2R)
    OC6.2
    Oral Communication 6: Metabolism & Cardiovascular
    Human adipocytes secrete new cardiodepressant factors: a direct link between obesity and heart failure
    OC6.3
    Oral Communication 6: Metabolism & Cardiovascular
    Visfatin induces MMP-2/9 activation in human vascular endothelial cells via nuclear factor-кB
    OC6.4
    Oral Communication 6: Metabolism & Cardiovascular
    Lipolysis in subcutaneous adipose tissue after intranasal administration of ACTH(4-10) is associated with an increased baroreceptor reflex sensitivity.
    OC6.5
    Oral Communication 6: Metabolism & Cardiovascular
    Association of the SHBG gene promotor polymorphism with early markers of atherosclerosis in apparently healthy women
    OC6.6
    Oral Communication 6: Metabolism & Cardiovascular
    Androgens increase blood pressure in orchiectomized male Wistar rats similar to high salt diet
    OC6.7
    Oral Communication 6: Metabolism & Cardiovascular
    The mineralocorticoid receptor induces pro-inflammatory effects in white adipocytes and is essential for adipogenesis.
    OC6.8
    Oral Communication 6: Metabolism & Cardiovascular
    Chronic prostaglandin excess results in adipose tissue wasting through increased substrate utilization
    OC6.9
    Oral Communication 6: Metabolism & Cardiovascular
    The histone deacetylase inhibitor valproic (VPA) confers an estrogen-sensitive “Phenotype” to estrogen receptor-negative breast cancer cells MDA-MB 231.
    17:15 - 18:00 
    Plenary Lecture 6
    HALL 1
    Chairs: A. Lewinski (Poland) & M. Alevizaki (Greece)
    PL6
    Plenary Lecture 6
    Graves' Opthalmopathy - Problems solved and new questions to be answered
    18:00 - 18:15 
    Young Investigator Awards & Poster Awards
    HALL 1
    18:15 - 19:30 
    Annual General Meeting of the European Society of Endocrinology (ESE)
    HALL 1
    20:00 - 23:00 
    ECE Gala Dinner at Loewesaal
    Loewesaal

    08:30 - 10:00 
    Symposium 27 - Clinical: Nodules and more: new aspects of thyroid disorders
    HALL 1
    Chairs: M. Erdogan (Turkey) & S. Mariotti (Italy)
    S27.1
    Symposium 27 - Clinical: Nodules and more: new aspects of thyroid disorders
    Management of thyroid nodules: The European and the USA way
    S27.2
    Symposium 27 - Clinical: Nodules and more: new aspects of thyroid disorders
    Management of differentiated thyroid cancer.
    S27.3
    Symposium 27 - Clinical: Nodules and more: new aspects of thyroid disorders
    Therapeutic options and dilemmas in medullary thyroid carcinoma
    S27.4
    Symposium 27 - Clinical: Nodules and more: new aspects of thyroid disorders
    Nodules and more
    08:30 - 10:00 
    Symposium 28 - Basic: GH: structure - function relationship
    HALL 7
    Chairs: P. Mollard (France) & C. Strasburger (Germany)
    S28.1
    Symposium 28 - Basic: GH: structure - function relationship
    Plasticity in the Growth Hormone Axis
    S28.2
    Symposium 28 - Basic: GH: structure - function relationship
    The contribution of autocrine human growth hormone to neoplasia
    S28.3
    Symposium 28 - Basic: GH: structure - function relationship
    Multireceptor ligands in the treatment of pituitary adenomas
    S28.4
    Symposium 28 - Basic: GH: structure - function relationship
    Trafficking and Function of GHR and the Role of GHBP
    08:30 - 10:00 
    Symposium 29 - Translational: Too early-too late: The timing of puberty
    HALL 3
    Chairs: A. Huebner (Germany) & A. Juul (Denmark)
    S29.1
    Symposium 29 - Translational: Too early-too late: The timing of puberty
    The Systems Biology of Puberty-Searching for Hypothalamic Gene Networks
    S29.2
    Symposium 29 - Translational: Too early-too late: The timing of puberty
    Long acting GnRH analogues in the treatment of Central Precocious Puberty
    S29.3
    Symposium 29 - Translational: Too early-too late: The timing of puberty
    Estrogen and kisspeptin regulation of GnRH neurons at puberty
    S29.4
    Symposium 29 - Translational: Too early-too late: The timing of puberty
    Human genetics of pubertal onset
    08:30 - 10:00 
    Symposium 30: Clinical Highlights
    HALL 4/5
    Chairs: J. Salvador (Spain) & A. Colao (Italy)
    S30.1
    Symposium 30: Clinical Highlights
    Reversible Kallmann syndrome associated with a novel homozygous mutation in the prokineticin receptor-2 gene
    S30.2
    Symposium 30: Clinical Highlights
    Contrast-enhanced ultrasound of adrenal mass: Differentiation between benign and malignant lesions
    S30.3
    Symposium 30: Clinical Highlights
    [123I]Iodometomidate as a radiotracer for diagnosis of adrenal tumours and adrenocortical carcinoma
    S30.4
    Symposium 30: Clinical Highlights
    Evaluation of endothelial function nitric oxide synthase intron 4a/b polymorphism in primary hyperparathyroidism
    S30.5
    Symposium 30: Clinical Highlights
    Increased prevalence of tricuspid regurgitation in patients with prolactinomas chronically treated with cabergoline: dose and treatment duration effect
    S30.6
    Symposium 30: Clinical Highlights
    Association of pioglitazone treatment with decreased bone mineral density in obese premenopausal patients with polycystic ovary syndrome: a randomized, placebo-controlled trial.
    10:05 - 10:50 
    Plenary Lecture 7
    HALL 1
    Chairs: J.L. Medina (Portugal) & E. Ghigo (Italy)
    PL7
    Plenary Lecture 7
    Decreased sleep duration and quality: novel risk factors for obesity and diabetes
    10:50 - 11:15 
    Coffee Break & Exhibition
    11:15 - 12:15 
    Meet the Professor 13: Endocrine management of gonadal tissue conservation
    Hall 1
    ME13
    Meet the Professor 13: Endocrine management of gonadal tissue conservation
    Endocrine management of gonadal tissue conservation
    11:15 - 12:15 
    Meet the Professor 14: Management of GI-NET
    HALL 7
    ME14
    Meet the Professor 14: Management of GI-NET
    Management of GI-NET
    11:15 - 12:15 
    Meet the Professor 15: Histopathology of thyroid tumors
    HALL 3
    ME15
    Meet the Professor 15: Histopathology of thyroid tumors
    Histopathology of Thyroid Tumors
    11:15 - 12:15 
    Meet the Professor 16: HRT in women - a never ending story?
    HALL 4/5
    ME16
    Meet the Professor 16: HRT in women - a never ending story?
    HRT in women – a never ending story?
    12:15 - 12:30 
    Plenary Lecture 8
    HALL 1
    Chairs: C. Dieguez (Spain) & S. Farooqi (UK)
    PL8
    Plenary Lecture 8
    Central regulation of appetite and body weight – the role of peripheral signals
    12:50 - 13:00 
    Farewell and Invitations to Istanbul
    HALL 1
N.Barzilai
Sun 04 17:15
PL2
Plenary Lecture 2
Why did Moses live to be 120?
E.Challet
Mon 05 09:30
S12.4
Symposium 12 - Translational: Addicted to Food?
Metabolic and reward cues affect the central clock in the brain
J. Achermann
Sun 04 15:50
S9.2
Symposium 9 - Clinical: New aspects of adrenal disease
The expanding spectrum of DAX1 and SF1 mutations
J. Acunzo
Tue 06 08:30
S20.1
Symposium 20: Translational Highlights
sst2 gene transfer restores the somatostatin agonist sensitivity of human resistant pituitary adenomas, in vitro
W. Arlt
Sun 04 09:30
S1.4
Symposium 1 - Clinical: The trick is the combination
The combined Androgen and Estrogen replacement therapy in women
R. Asci
Wed 07 08:30
S30.1
Symposium 30: Clinical Highlights
Reversible Kallmann syndrome associated with a novel homozygous mutation in the prokineticin receptor-2 gene
J. Auwerx
Mon 05 10:05
PL3
Plenary Lecture 3
A cofactor network that controls PGC-1alpha activity and energy homeostasis
J. Bach
Sun 04 08:30
S3.1
Symposium 3 - Translational: Gene / Environment interactions in autoimmune endocrine disease
Why is the incidence of autoimmune diseases increasing in the modern world?
L. Bartalena
Sun 04 08:30
S1.1
Symposium 1 - Clinical: The trick is the combination
Treatment of hyperthyroidism: block and replace versus titration
R. Batterham
Mon 05 08:50
S12.2
Symposium 12 - Translational: Addicted to Food?
Peptide YY: Cure for obesity?
M. Bidlingmaier
Tue 06 09:10
S18.3
Symposium 18 - Clinical: Doping - an issue for clinical endocrinologists
Distinction between endogenous and exogenous GH
B. Bidzinska-Speichert
Mon 05 16:30
S16.4
Symposium 16 - Clinical: New insights in PCOS
Treatment of PCOS
C. Birchmeier
Sun 04 11:35
S6.2
Symposium 6 - Translational: Insights in pancreatic development and new clinical aspects
The zinc-finger factor Insm1 (IA-1) is essential for the development of endocrine cells of the pancreas, intestine and adrenal gland.
W. Blum
Mon 05 11:15
S15.1
Symposium 15 - Clinical: GH treatment of syndromic short stature-facts and myths
SHOX Deficiency: Does GH Treatment Do any Good?
A. Bojesen
Sun 04 11:55
S4.3
Symposium 4 - Clinical: Is there a crisis of male reproduction?
Metabolic syndrome in Klinefelter syndrome (47,XXY)
M. Bolanowski
Tue 06 14:30
ME10
Meet the Expert 10: How to prevent osteoporosis?
How to prevent osteoporosis?
G.B. Bolli
Sun 04 14:30
ME2
Meet the Expert 2: The necessity of Insulin analogues
Rational for using insulin analogues in the treatment of diabetes mellitus
G. Brabant
Wed 07 09:30
S27.4
Symposium 27 - Clinical: Nodules and more: new aspects of thyroid disorders
Nodules and more
J. Brosens
Sun 04 12:15
S5.4
Symposium 5 - Basic: Protein modifications / Proteomics
Progesterone Receptor Responses Modified by SUMO in the Endometrium
T. Brue
Wed 07 09:10
S28.3
Symposium 28 - Basic: GH: structure - function relationship
Multireceptor ligands in the treatment of pituitary adenomas
J. Brüning
Wed 07 12:15
PL8
Plenary Lecture 8
Central regulation of appetite and body weight – the role of peripheral signals
D. Calebiro
Germany
Mon 05 11:15
S14.1
Symposium 14: Basic Highlights
Direct vizualization of cyclic AMP levels in three dimensional cultures of thyroid follicles
Germany
J.C. Carel
Wed 07 08:50
S29.2
Symposium 29 - Translational: Too early-too late: The timing of puberty
Long acting GnRH analogues in the treatment of Central Precocious Puberty
N. Carrasco
Mon 05 16:30
S17.4
Symposium 17 - Basic: Thyroid Cell Biology
Novel insights on the Na+/I- symporter (NIS): it mediates electroneutral active transport of the environmental pollutant perchlorate.
J. Castano
Tue 06 11:35
S23.2
Symposium 23 - Translational: Towards a better understanding of hypothalamic - pituitary disorders
Atypical G-protein coupled receptor expression in pituitary tumors
E. Cauter
Wed 07 10:05
PL7
Plenary Lecture 7
Decreased sleep duration and quality: novel risk factors for obesity and diabetes
C. Cervino
Mon 05 12:30
S14.6
Symposium 14: Basic Highlights
Specific neuronal deletion of cannabinoid type 1 receptor (CB1) mice exhibits reduced fat mass and diet-induced obesity resistance
N. Chabbert-Buffet
Wed 07 11:15
ME16
Meet the Professor 16: HRT in women - a never ending story?
HRT in women – a never ending story?
L. Chatenoud
Tue 06 16:10
S26.3
Symposium 26 - Clinical: New therapeutic options in diabetes
Emerging therapeutic approaches to preserve beta cell function in Type 1 DM
G. Chrousos
Sat 03
GH1
Opening Ceremony: Geoffrey Harris Prize Lecture
From Geoffrey Harris' hypothalamic principle to a unified theory of stress and stress system disorders
P. Clayton
Mon 05 12:15
S15.4
Symposium 15 - Clinical: GH treatment of syndromic short stature-facts and myths
Consensus on GH Treatment in SGA
A-M. Colao
Wed 07 09:30
S30.5
Symposium 30: Clinical Highlights
Increased prevalence of tricuspid regurgitation in patients with prolactinomas chronically treated with cabergoline: dose and treatment duration effect
S. Corbetta
Tue 06 09:30
S20.5
Symposium 20: Translational Highlights
V206M polymorphism of the SLC26A6 gene encoding a Cl--oxalate transporter in patients with primary hyperparathyroidism and kidney stones.
D. Cota
Mon 05 09:10
S12.3
Symposium 12 - Translational: Addicted to Food?
Hypothalamic regulation of energy balance
J. Dahlgren
Mon 05 11:35
S15.2
Symposium 15 - Clinical: GH treatment of syndromic short stature-facts and myths
GH therapy in Noonan Syndrome – facts and myths
M.T. Dattani
Tue 06 11:15
S23.1
Symposium 23 - Translational: Towards a better understanding of hypothalamic - pituitary disorders
Pituitary Development and Congenital Hypopituitarism (CH)
O. Dekkers
Tue 06 15:30
S24.1
Symposium 24 - Clinical: State of the art in therapy of pituitary disease
Nonfunctioning pituitary macroadenomas: treatment and follow-up
P.J. Delhanty
Sun 04 16:10
S7.3
Symposium 7 - Translational: The functions of peripheral GHrelin
Ghrelin and Bone
E. Diamanti-Kandarakis
Mon 05 16:10
S16.3
Symposium 16 - Clinical: New insights in PCOS
Vascular markers in PCOS
P. Dijke
Sun 04 08:30
S2.1
Symposium 2 - Basic: The TGF-beta Superfamily
BMP to the Bone
I. Dikic
Sun 04 11:55
S5.3
Symposium 5 - Basic: Protein modifications / Proteomics
Targeting ubiquitin networks
M Dolmans
Wed 07 11:15
ME13
Meet the Professor 13: Endocrine management of gonadal tissue conservation
Endocrine management of gonadal tissue conservation
G.S. Eisenbarth
Sun 04 09:10
S3.3
Symposium 3 - Translational: Gene / Environment interactions in autoimmune endocrine disease
Gene Environment Interactions in Type 1 Diabetes
A. Ekmekci
Wed 07 09:15
S30.4
Symposium 30: Clinical Highlights
Evaluation of endothelial function nitric oxide synthase intron 4a/b polymorphism in primary hyperparathyroidism
B. Fauser
Mon 05 15:30
S16.1
Symposium 16 - Clinical: New insights in PCOS
Definition of PCOS
U. Feldt-Rasmussen
Tue 06
Symposium 21 - Pro & Con: Is there a benefit of treatment of subclinical hypothyroidism?
PRO
P. Fiorina
Tue 06 15:30
S26.1
Symposium 26 - Clinical: New therapeutic options in diabetes
Islet transplantation
G. Forti
Mon 05
Symposium 13 - Pro & Con: HRT or more Androgen therapy of the aging male
CON
P. Friedl
Sun 04 14:30
ME4
Meet the Expert 4: A living method: In vivo microscopy
Two-photon microscopy of cancer invasion and metastasis
M. Friedrich-Rust
Wed 07 08:45
S30.2
Symposium 30: Clinical Highlights
Contrast-enhanced ultrasound of adrenal mass: Differentiation between benign and malignant lesions
P. Froguel
Tue 06 16:30
S26.4
Symposium 26 - Clinical: New therapeutic options in diabetes
The one and only? Gene driving Type 2 DM
D. Führer
Sun 04 11:35
S5.2
Symposium 5 - Basic: Protein modifications / Proteomics
Applying proteomics to thyroid tumour diagnosis
A. Fusco
Mon 05 16:10
S17.3
Symposium 17 - Basic: Thyroid Cell Biology
Molecular mechanisms of thyroid carcinogenesis: role of the CBX7 gene.Loss of the CBX7 gene.ll
V. Gawlik
Mon 05 12:00
S14.4
Symposium 14: Basic Highlights
Targeted disruption of Slc2a8 (GLUT8) reduces ATP levels and mitochondrial potential of spermatozoa
A-P. Gimenez-Roqueplo
Sun 04 16:30
S9.4
Symposium 9 - Clinical: New aspects of adrenal disease
Genetics of chromaffin tumours
D. Glintborg
Wed 07 09:45
S30.6
Symposium 30: Clinical Highlights
Association of pioglitazone treatment with decreased bone mineral density in obese premenopausal patients with polycystic ovary syndrome: a randomized, placebo-controlled trial.
D. Grammatopoulos
Tue 06 08:30
S19.1
Symposium 19 - Translational: Hormone receptors and adipose tissue
The family of corticotropin-releasing hormone (CRH) peptides; important regulators of adipocyte function
R. Granata
Sun 04 15:50
S7.2
Symposium 7 - Translational: The functions of peripheral GHrelin
Ghrelin and the endocrine pancreas
S. Güllü
Tue 06 14:30
ME9
Meet the Expert 9: An underestimated hormone: Prolactin
Prolactin: An underestimated hormone
A. Hackney
Tue 06 08:30
S18.1
Symposium 18 - Clinical: Doping - an issue for clinical endocrinologists
Indirect evidence suggesting hormone abuse -- can it be proof of doping in sports?
S. Hahner
Wed 07 09:00
S30.3
Symposium 30: Clinical Highlights
[123I]Iodometomidate as a radiotracer for diagnosis of adrenal tumours and adrenocortical carcinoma
A. Hattersley
Tue 06 10:05
PL5
Plenary Lecture 5
Too little and too much insulin: lessons from Newborns
L. Hegedüs
Sun 04 09:30
S3.4
Symposium 3 - Translational: Gene / Environment interactions in autoimmune endocrine disease
Gene-environment interactions in thyroid autoimmunity.
A. Herbison
Wed 07 09:10
S29.3
Symposium 29 - Translational: Too early-too late: The timing of puberty
Estrogen and kisspeptin regulation of GnRH neurons at puberty
W.von Herder
Wed 07 11:15
ME14
Meet the Professor 14: Management of GI-NET
Management of GI-NET
V. Heyningen
Mon 05 08:50
S11.2
Symposium 11 - Basic: Epigenetics in endocrinology
Mechanisms of selective gene expression in development
O. Hiort
Tue 06 14:30
ME11
Meet the Expert 11: More than a change of nomenclature disorders of sexual differentiation (DSD)
More than a change of nomenclature: Disorders of Sex Development (DSD)
B. Hofmann
Mon 05 09:10
DGE Hormone Toxicology: Is there a threat of endocrine disruptors?
Plant derived compunds with endocrine actions: Hops and Xanthohumols
A. Hokken-Koelega
Mon 05 11:55
S15.3
Symposium 15 - Clinical: GH treatment of syndromic short stature-facts and myths
GH therapy in children with Prader Willi Syndrome (PWS)
P. Holterhus
Mon 05 15:50
DGE Symposium Young Reasearchers (DGE): Embryonic Development of Endocrine Organs
Sexual differentiation - What makes the difference?
B. Horsthemke
Mon 05 08:30
S11.1
Symposium 11 - Basic: Epigenetics in endocrinology
Epimutations in the human genome
D. Hunter
Sun 04 08:50
S3.2
Symposium 3 - Translational: Gene / Environment interactions in autoimmune endocrine disease
Genome-wide association studies and hormone-dependent cancers
K. Hussain
Sun 04 11:55
S6.3
Symposium 6 - Translational: Insights in pancreatic development and new clinical aspects
Hyperinsulinism in humans
W. Huttner
Tue 06 16:10
S25.3
Symposium 25 - Basic: Stem cell and regeneration
The cell biology of neural stem and progenitor cells
L. Ibáñez
Mon 05 15:50
S16.2
Symposium 16 - Clinical: New insights in PCOS
New insights in Polycystic Ovary Syndrome
J. Janssen
Sun 04 08:50
S1.2
Symposium 1 - Clinical: The trick is the combination
The combination of GH/IGF-I makes the difference!
H. Jarry
Mon 05 08:50
DGE Hormone Toxicology: Is there a threat of endocrine disruptors?
Endocrine disruptors and reproductive hormones
B. Jarzab
Wed 07 09:10
S27.3
Symposium 27 - Clinical: Nodules and more: new aspects of thyroid disorders
Therapeutic options and dilemmas in medullary thyroid carcinoma
N. Joergensen
Sun 04 11:15
S4.1
Symposium 4 - Clinical: Is there a crisis of male reproduction?
Deterioration of male reproductive function in Europe. Geographical differences
G. Johansson
Sun 04 16:10
S9.3
Symposium 9 - Clinical: New aspects of adrenal disease
REPLACEMENT AND QoL IN PATIENTS WITH ADRENAL INSUFFICIENCY
J. Jorgensen
Sun 04 09:10
S1.3
Symposium 1 - Clinical: The trick is the combination
Medical Treatment of Acromegaly: Dual Blockade with a Somatostatin Analog and Pegvisomant
T. Kadowaki
Tue 06 09:30
S19.4
Symposium 19 - Translational: Hormone receptors and adipose tissue
Adiponectin and its receptors in insulin resistance, diabetes, and metabolic syndrome, and obesity.
J. Klein
Tue 06 08:50
S19.2
Symposium 19 - Translational: Hormone receptors and adipose tissue
Corticosteroid receptors and adipocytes
J. Kohrle
Mon 05 08:30
DGE Hormone Toxicology: Is there a threat of endocrine disruptors?
Endocrine disruptors and the thyroid
A. Kralli
Sun 04 16:30
S8.4
Symposium 8 - Basic: Nuclear Receptors
Estrogen-related receptors as regulators of energy homeostasis and adaptive metabolism
R. Krasnoperov
Tue 06 09:15
S20.4
Symposium 20: Translational Highlights
Recent advances in stereological methods for studying microvessels in endocrine organs
H. Krude
Mon 05 16:30
DGE Symposium Young Reasearchers (DGE): Embryonic Development of Endocrine Organs
Walking the line - the thyroid gland development
R. Leibel
Mon 05 17:15
PL4
Plenary Lecture 4
Genetics of Obesity
C. Lengerke
Tue 06 15:30
S25.1
Symposium 25 - Basic: Stem cell and regeneration
Generation and patterning of patient-specific pluripotent stem cells
R. Libé
Mon 05 11:45
S14.3
Symposium 14: Basic Highlights
Variants of the phosphodiesterase 11A (PDE11A4) gene and genetic predisposition to adrenocortical tumors (ACT)
P. Lobie
Wed 07 08:50
S28.2
Symposium 28 - Basic: GH: structure - function relationship
The contribution of autocrine human growth hormone to neoplasia
B. Lunenfeld
Mon 05
Symposium 13 - Pro & Con: HRT or more Androgen therapy of the aging male
PRO
F. Magkos
Tue 06 11:15
S22.1
Symposium 22 - Clinical: The metabolic effects of exercise
Mechanisms for the delayed effects of exercise on lipid and lipoprotein metabolism
K. Main
Sun 04 11:35
S4.2
Symposium 4 - Clinical: Is there a crisis of male reproduction?
Life style factors and chemical exposures impair male reproductive development and function in humans
M. Malumbres
Tue 06 12:15
S23.4
Symposium 23 - Translational: Towards a better understanding of hypothalamic - pituitary disorders
Cell cycle control and proliferative diseases of the pituitary
F. Mantero
Mon 05 14:30
ME5
Meet the Expert 5: How valid is a biochemical diagnosis of chromaffin tumors?
How valid is a biochemical diagnosis of chromaffin tumors?
G. Mastorakos
Sun 04 14:30 - 15:30
ME3
Meet the Expert 3: Contraception in the new millennium
Contraception in the New Millennium
P. Mehlen
Sun 04 09:30
S2.4
Symposium 2 - Basic: The TGF-beta Superfamily
The Dependence Receptor notion: When apoptosis regulates tumor progression and metastasis
M. Mendelssohn
Sun 04 10:05
PL1
Plenary Lecture 1
Estrogens and cardiovascular disease
D. Micic
Sun 04 14:30
ME1
Meet the Expert 1: The impact of abdominal obesity
The impact of abdominal obesity
J. Moreno
Tue 06 09:00
S20.3
Symposium 20: Translational Highlights
Monoallelic mutations in DUOXA2 are associated with mild permanent hypothyroidism and goiter.
J. Nauman
Tue 06
Symposium 21 - Pro & Con: Is there a benefit of treatment of subclinical hypothyroidism?
CON
John Newell-Price
Sheffield, UK
Tue 06 16:10
S24.3
Symposium 24 - Clinical: State of the art in therapy of pituitary disease
The Sequealae of Cushing’s Disease
Sheffield, UK
T. Nilsson
Sun 04 11:15
S5.1
Symposium 5 - Basic: Protein modifications / Proteomics
Comparative proteomics as a tool in biology: The protein microscope
P. Njolstad
Sun 04 12:15
S6.4
Symposium 6 - Translational: Insights in pancreatic development and new clinical aspects
Carboxylester lipase (CEL) VNTR links exocrine dysfunction to endocrine dysfunction
B. Noble
Tue 06 12:15
S22.4
Symposium 22 - Clinical: The metabolic effects of exercise
Exercise and Bone
C. Ohlsson
Sat 03
EJE1
Opening Ceremony: European Journal of Endocrinology Prize Lecture
Sex Steroids in the Regulation of Bone Metabolism in Men
S. Ojeda
Wed 07 08:30
S29.1
Symposium 29 - Translational: Too early-too late: The timing of puberty
The Systems Biology of Puberty-Searching for Hypothalamic Gene Networks
H. Ong
Sun 04 16:30
S7.4
Symposium 7 - Translational: The functions of peripheral GHrelin
Peptidyl growth hormone secretagogues in cardioprotection
M. Oresic
Tue 06 14:30
ME12
Meet the Expert 12: Metabolomics and metabolics
Metabolomics and metabonomics
T. Otonkoski
Tue 06 15:50
S26.2
Symposium 26 - Clinical: New therapeutic options in diabetes
Regeneration of pancreatic beta cells
F. Pacini
Wed 07 08:50
S27.2
Symposium 27 - Clinical: Nodules and more: new aspects of thyroid disorders
Management of differentiated thyroid cancer.
R. Paschke
Wed 07 08:30
S27.1
Symposium 27 - Clinical: Nodules and more: new aspects of thyroid disorders
Management of thyroid nodules: The European and the USA way
B. Pedersen
Tue 06 11:35
S22.2
Symposium 22 - Clinical: The metabolic effects of exercise
Inflammation and physical activity
N. Perakakis
Mon 05 12:15
S14.5
Symposium 14: Basic Highlights
KLF11 differentially regulates PDX1-induced activation of the human insulin promoter in rodent beta-cells and human non-beta-cells
A. Peters
Mon 05 08:30
S12.1
Symposium 12 - Translational: Addicted to Food?
The Selfish Brain: Competition for Energy Resources
R. Pivonello
Tue 06 15:50
S24.2
Symposium 24 - Clinical: State of the art in therapy of pituitary disease
Medical therapy of Cushing's Disease
Dr. Pogoda
Mon 05 15:30
DGE Symposium Young Reasearchers (DGE): Embryonic Development of Endocrine Organs
Trekking the midline-development of the hypothalamus and the pituitary
J. Polak
Tue 06 11:55
S22.3
Symposium 22 - Clinical: The metabolic effects of exercise
Why does physical exercise improve insulin sensitivity, the role of adipose tissue ?
I. Robinson
Wed 07 08:30
S28.1
Symposium 28 - Basic: GH: structure - function relationship
Plasticity in the Growth Hormone Axis
C. Rochette-Egly
Sun 04 15:50
S8.2
Symposium 8 - Basic: Nuclear Receptors
Kinase signaling and retinoic acid nuclear receptors
R.J. Ross
Wed 07 09:30
S28.4
Symposium 28 - Basic: GH: structure - function relationship
Trafficking and Function of GHR and the Role of GHBP
N. Roux
Wed 07 09:30
S29.4
Symposium 29 - Translational: Too early-too late: The timing of puberty
Human genetics of pubertal onset
E. Saez
Sun 04 15:30
S8.1
Symposium 8 - Basic: Nuclear Receptors
LXR
P. Santisteban
Mon 05 15:50
S17.2
Symposium 17 - Basic: Thyroid Cell Biology
Growth Factors Involved In Thyroid Cells Differentiation
M. Savage
Mon 05
Symposium 10 - Pro & Con: Is there a rationale for ISS treatment with GH
CON
W. Schänzer
Tue 06 08:50
S18.2
Symposium 18 - Clinical: Doping - an issue for clinical endocrinologists
Doping with Androgens
R. Scharfmann
Mon 05 16:10
DGE Symposium Young Reasearchers (DGE): Embryonic Development of Endocrine Organs
A long way from its roots - the pancreatic beta cell
M. Scherr
Mon 05 14:30
ME8
Meet the Expert 8: MicroRNA
microRNA
S. Schlatt
Tue 06 15:50
S25.2
Symposium 25 - Basic: Stem cell and regeneration
Stem cells in the gonads: Novel options for fertility preservation?
A. Schneyer
Sun 04 09:10
S2.3
Symposium 2 - Basic: The TGF-beta Superfamily
TGF-beta family ligands in glucose and fat homeostasis in adults
R. Schüle
Sun 04 16:10
S8.3
Symposium 8 - Basic: Nuclear Receptors
Phosphorylation of histone H3 at threonine 11 establishes a novel chromatin mark for transcriptional regulation
J. Segura
Tue 06 09:30
S18.4
Symposium 18 - Clinical: Doping - an issue for clinical endocrinologists
Distinction between endogenous and exogenous erythropoietin (EPO)
H. Semb
Tue 06 16:30
S25.4
Symposium 25 - Basic: Stem cell and regeneration
Beta cell progenitor niche(s) and derivation of such cells from human ES cells
M. Simoes
Wed 07 11:15
ME15
Meet the Professor 15: Histopathology of thyroid tumors
Histopathology of Thyroid Tumors
F. Spagnoli
Sun 04 11:15
S6.1
Symposium 6 - Translational: Insights in pancreatic development and new clinical aspects
Embryonic Pancreatic Development
T. Spanic
Tue 06 08:45
S20.2
Symposium 20: Translational Highlights
SF-1 knockout mice as a model for hormone independent brain sexual differentiation
G. Stalla
Tue 06 11:55
S23.3
Symposium 23 - Translational: Towards a better understanding of hypothalamic - pituitary disorders
Growth factors in pituitary tumour development
G. Stein
Sun 04 08:50
S2.2
Symposium 2 - Basic: The TGF-beta Superfamily
Integration of Skeletal Regulatory Signals in Nuclear Microenvironments
F. Tanriverdi
Mon 05 14:30
ME7
Meet the Expert 7: The sequelae of brain injury – is the pituitary involved?
The sequelae of brain injury – is the pituitary involved?
K. Temple
Mon 05 09:30
S11.4
Symposium 11 - Basic: Epigenetics in endocrinology
Imprinting in Human Disease – Lessons from the study of Transient Neonatal Diabetes
M. Tena-Sempere
Sun 04 15:30
S7.1
Symposium 7 - Translational: The functions of peripheral GHrelin
Ghrelin and the Gonads
M. Toth
Mon 05 14:30
ME6
Meet the Expert 6: Beyond the bone – sporadic and hereditary hyperparathyroidism.
Beyond the bone – sporadic and hereditary hyperparathyroidism.
J. Visser
Tue 06 09:45
S20.6
Symposium 20: Translational Highlights
A functional AMH polymorphism is associated with follicle number and androgen levels in Polycystic Ovary Syndrome patients
G. Vollmer
Mon 05 09:30
DGE Hormone Toxicology: Is there a threat of endocrine disruptors?
Danger of combination? Interactions of low ose hormone therapy with phytoestrogens
S.M. Webb
Tue 06 16:30
S24.4
Symposium 24 - Clinical: State of the art in therapy of pituitary disease
Development of a disease-related QoL-questionnaire for Cushing’s disease
T. Wells
Tue 06 09:10
S19.3
Symposium 19 - Translational: Hormone receptors and adipose tissue
Multi-layered receptor interactions in ghrelin-induced fat deposition
W. Wiersinga
Tue 06 17:15
PL6
Plenary Lecture 6
Graves' Opthalmopathy - Problems solved and new questions to be answered
J.M. Wit
Mon 05
Symposium 10 - Pro & Con: Is there a rationale for ISS treatment with GH
PRO
K. Zacharowski
Sun 04 15:30
S9.1
Symposium 9 - Clinical: New aspects of adrenal disease
The role of toll-like receptors
S. Zannini
Mon 05 15:30
S17.1
Symposium 17 - Basic: Thyroid Cell Biology
Basic mechanisms of thyroid development
M. Zatelli
Mon 05 11:30
S14.2
Symposium 14: Basic Highlights
Dopamine receptor 2 activation reduces cells viability in non functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion
M. Zernicka-Goetz
Mon 05 09:10
S11.3
Symposium 11 - Basic: Epigenetics in endocrinology
Epigenetics in mammalian development
M. Zitzmann
Sun 04 12:15
S4.4
Symposium 4 - Clinical: Is there a crisis of male reproduction?
Metabolic Aspects of Testosterone Replacement
Workshop 0
Oral 0
Expert 0
Plenary 0
Catering and Social 0
Nurse 0
Other 0
Symposium 0
No Session Type 0

0 result(s) found.

Please wait...

     
      - 
     
     
     


    Abstracts from this event
      Abstracts from other events


          Session starts at:
          Abstract time:
        Event:


        Read full abstract